PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Testosterone - Low sexual desire in menopausal women

PAD Profile : Testosterone - Low sexual desire in menopausal women

Keywords :
reduced sex drive, low sex drive, reduced sexual function, female sexual dysfunction, hypoactive sexual desire disorder, low libido
Brand Names Include :
Androfeme

Traffic Light Status

Status 1 of 2.

Status :
Non Formulary
Important
Formulations :
  • Cream
Important Information :
Androfeme is unlicensed in the UK. Other products can be used off-label
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :

To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'

Documents :

Status 2 of 2.

Status :
Green
Important
Formulations :
  • Gel
Important Information :
Prescribe generically as "Testosterone 2% transdermal gel 60g"
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Un
Comments :

To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
11 September 2024
Surrey Heartlands Medicines Safety Committee (MSC)

To support the safe use of testosterone in menopause please note the 'BMS Statement on Testosterone'

07 February 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Health System Area Prescribing Committee (APC) has agreed that topical testosterone should be prescribed generically, ideally using Drug Tariff descriptions.

06 December 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approved a change in traffic light status from BLUE to GREEN for testosterone gel.

The following testosterone products are NON-FORMULARY as they are either unlicensed in the UK or not available in biologically appropriate doses for the indication: Androfeme, Testogel, Testavan

Please note; Testim has been discontinued.

04 October 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed that treatment of low sexual desire in menopausal women with testosterone 1% cream will be given a NON-FORMULARY traffic light status.

Androfeme 1% cream is unlicensed in the UK and there are licensed testosterone preparations available that are being used off-label.

Associated BNF Codes

06. Endocrine System
06.04.02. Male sex hormones and antagonists
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More